SYNAIRGEN PLC Logo

SYNAIRGEN PLC

SNG | IL

Overview

Corporate Details

ISIN(s):
GB00B0381Z20
LEI:
213800IMMTOPPDF8HD24
Country:
United Kingdom
Address:
MAILPOINT 810 LEVEL F, SO16 6YD SOUTHAMPTON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Synairgen is a respiratory biotech company developing inhaled interferon beta (IFN-_) for severe viral lung infections, aiming for a first-of-its-kind, broad-spectrum antiviral treatment delivered directly to the lungs [1].

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-16 08:00
Board/Management Information
Board and Executive Leadership Changes
English 9.8 KB
2025-03-28 15:21
Post-Annual General Meeting Information
Result of General Meeting
English 18.6 KB
2025-03-11 08:00
Pre-Annual General Meeting Information
Proposed cancellation of trading on AIM
English 76.3 KB
2025-01-17 13:55
Major Shareholding Notification
Holding(s) in Company
English 51.8 KB
2025-01-16 16:42
Board/Management Information
Martin Murphy appointed as Non-Executive Director
English 17.9 KB
2025-01-16 16:42
Post-Annual General Meeting Information
Result of General Meeting and Total Voting Rights
English 13.5 KB
2025-01-15 18:37
Share Issue/Capital Change
£18m raised to fund Phase 2 INVENT clinical trial
English 14.8 KB
2024-12-20 08:00
Share Issue/Capital Change
Proposed Fundraising
English 398.7 KB
2024-10-30 19:09
Share Issue/Capital Change
Exercise of Share Options and Total Voting Rights
English 10.5 KB
2024-10-10 18:05
Post-Annual General Meeting Information
Results of AGM and Appointment of New Chairman
English 10.8 KB
2024-09-26 08:00
Interim Report
Interim Results
English 143.5 KB
2024-09-18 08:00
Board/Management Information
Appointment of New Chairman and Notice of AGM
English 17.7 KB
2024-09-05 08:00
Board/Management Information
Board Change
English 11.1 KB
2024-06-27 08:00
Earnings Release
2023 Full Year Results
English 129.1 KB
2023-11-15 08:00
Share Issue/Capital Change
Grant of Options
English 28.7 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies